[The use of a colony-stimulating factor (G-CSF) in iatrogenic neutropenias].
D000368:Aged; D002216:Captopril / Q000009:adverse effects; D002437:Cefazolin / Q000009:adverse effects; D003115:Colony-Stimulating Factors / Q000627:therapeutic use*; D005260:Female; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D007049:Iatrogenic Disease; D009503:Neutropenia / Q000139:chemically induced / Q000628:therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use*; D013988:Ticlopidine / Q000009:adverse effects
D003115:Colony-Stimulating Factors; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D002216:Captopril; D002437:Cefazolin; D013988:Ticlopidine; D000069585:Filgrastim
Utilización de factor estimulante de colonias (G-CSF) en neutropenias yatrógenas.